In its advertisement, Patanjali had cautioned consumers against buying chyawanprash which possess 41 Ayurvedic herbs—a fact highlighted by Dabur while promoting its product.
Healthcare sector accounted for a maximum 19% or 1,569 of 8,229 advertisements scrutinised by ASCI during 2023-24. Nearly 86% of drugs found illegal were on digital platforms.
Top court asserts consumers had a right to know whether they were being misled by FMCG companies too and what agencies were doing to prevent such misuse.
Yoga guru offers to publish a public apology for misleading ads by Divya Pharmacy, saying it 'happened on impulse' and that he would be careful in future.
In an affidavit before the SC, the Union Ayush ministry said it had issued repeated warnings to Patanjali. But it also slams petitioner IMA for ‘denigrating a system of medicine’.
Acharya Balkrishna says company regrets putting out the publicity campaign that questioned efficacy of modern medicine, but also termed the Drugs & Magic Remedies Act as 'archaic'.
Indian Medical Association has accused Patanjali of carrying out a smear campaign on evidence-based medicine. Court noted that no response filed by Patanjali on its contempt notice.
On 27 February, SC temporarily banned Patanjali from advertising certain products. But it was Babu K.V, a Kannur ophthalmologist, who began a fight against its 'misleading ads' in 2022.
West Asia conflict drains US stockpiles, forcing diversion of Patriot, THAAD interceptors from Kyiv; Europe, Zelensky voice concerns as US administration pivots funds and priorities
COMMENTS